Remilk

growth-negative

Remilk, an Israeli foodtech startup specializing in non-animal milk products, faces significant challenges as four senior board members resign due to disagreements with the companys management. Despite these setbacks, Remilk recently secured an additional $20 million from a new strategic investor, adding to the $150 million previously raised. The companys collaboration with Israeli dairy company Tara is uncertain, casting doubt on the launch of its milk products initially planned for June 2023. Remilks innovative fermentation technology aims to produce animal-free dairy proteins, but the company struggles with scaling production and maintaining partnerships. The resignations and partnership uncertainties highlight potential obstacles in Remilks path to market success.

growth-negative

The Israeli food-tech startup רימילק is facing a crisis as its chairman, תומר הרפז, and three other directors resigned due to a lack of confidence in the companys management and direction. Despite receiving approval from the Ministry of Health, רימילקs fermentation-based milk product has not been launched. The partnership with תרה, announced two years ago, is now uncertain. The company recently raised $20 million from a new strategic investor, adding to the $150 million previously raised. רימילקs plans to build a factory in Denmark have not materialized, and the company will produce its proteins through a third party. The resignations highlight internal disagreements and challenges in achieving the companys goals.

growth-positive

Remilk, a leading producer of precision fermentation dairy, has appointed three food industry executives to its Board of Directors. The executives bring insights and industry wisdom to the company, which is focused on crafting animal-free milk proteins through precision fermentation. Remilk aims to revolutionize the dairy industry by producing milk proteins identical to dairy using a unique fermentation process. The company has raised over $130 million and recently became the first precision fermentation dairy approved for sale in Israel. The addition of the new board members strengthens Remilks ability to become a driving force within the dairy industry.

growth-positive

Remilk, a startup in Israel, has received regulatory approval to market its animal-free dairy products. The company uses fermentation to produce cows milk proteins without the use of animals. Remilk will partner with Tara, a leading dairy product manufacturer in Israel, to release its initial products. The protein powder will be sold to manufacturers in Israel and globally. Remilk aims to provide a wide variety of dairy products without lactose, cholesterol, growth hormones, and antibiotics. The company believes that its technology can significantly reduce greenhouse gas emissions and offer a more financially sustainable solution for the struggling dairy industry. Remilk has raised approximately $150 million in funding from investors such as Precision Capital, Hanaco Ventures, OurCrowd, Tnuva, and the Central Beverage Company.

growth-positive

Israel has granted a permit to Remilk, a startup that produces real milk proteins from yeast, to sell its non-animal dairy products in the country. The permit is seen as a breakthrough and milestone for Israels technological leadership. Remilk uses a yeast-based fermentation process to create milk proteins that can be used to make various dairy products. The products are free of lactose, cholesterol, hormones, and antibiotics. The introduction of animal-free dairy products is expected to strengthen Israels economy, enhance food security, address climate change, and improve animal welfare. Remilk has raised over $130 million since its founding in 2019 and is already producing its protein at an industrial scale.

growth-positive

Israeli company Remilk has received approval to market its alternative milk protein in Israel. The company, which recently received FDA approval in the US and sales approval in Singapore, produces milk protein through fermentation of yeast. Remilk is a supplier of ingredients to food companies and has an agreement with Tera in Israel. The approval process in Israel is ongoing, and it is estimated that it will take a few months for the first Remilk-based product to reach the shelves. Prime Minister Netanyahu has shown interest in alternative protein and is expected to announce the marketing approval during his visit to Remilks offices.

growth-positive

Israeli foodtech startup Remilk has begun marketing its vegan cream cheese in the US in partnership with American food giant General Mills. The product, which is based on Remilks milk protein, is identical to those produced by cows but without the use of animals or animal ingredients. The company has raised $130 million since its establishment in 2019 and its last funding round in January 2022 valued it at $325 million. Remilk aims to replace traditional dairy products with its own, which require significantly less land, pollution, and water to produce.

growth-positive

Israeli foodtech startup Remilk has partnered with American food giant General Mills to market a vegan cream cheese made with Remilks protein. Remilk produces milk protein proteins with an innovative fermentation technology, fully imitating cows proteins without the use of animals. The company has raised about $130 million in funding and was valued at $325 million in its last fundraising round. The vegan cream cheese, which has the same taste, texture, and cost as traditional dairy cream cheese, is the first product to be launched commercially by Remilk. General Mills is also exploring the production of additional products with Remilks protein.

growth-positive

Israeli startup Remilk, which has developed milk proteins as an alternative to milk from cows, has been voted as the favorite startup in the Globes Most Promising Startups of 2022 ranking. Remilks milk proteins are identical to animal dairy proteins and are free of DNA, cholesterol, hormones, and antibiotics. The companys valuation has increased from $30 million in 2020 to $455 million in 2022. Remilk has raised $150 million to date from investors including Hanaco Ventures, Tal Ventures, Fresh Fund, and Precision Capital. The company has also obtained regulatory status from the US FDA and signed agreements with US food giants and Israeli dairy Tara. Remilks competitors in the alternative milk market include Perfect Day, New Culture, and Formo.

growth-positive

Remilk, an innovative food startup in the dairy industry, has appointed Tomer Harpaz as Chairman of the Board of Directors. Harpaz brings extensive experience as an entrepreneur and executive in the food industry. His appointment is expected to accelerate Remilks journey in reimagining the global dairy category. Harpaz shares Remilks vision for the future and believes in adopting disruptive technologies to drive sustainable change in the food systems. Remilk has achieved significant milestones, including raising over $120M in its second investment round, building a state-of-the-art precision-fermentation facility in Denmark, and collaborating with the Central Bottling Company for mass market products. Remilk produces animal-free milk proteins through a yeast-based precision fermentation process, offering dairy products that are indistinguishable in taste and function from traditional dairy but free of lactose, cholesterol, and growth hormones.

growth-positive

Israeli cultivated dairy company Remilk has received self-affirmed GRAS approval from the US FDA, allowing it to market its animal-free dairy-identical milk proteins in the US. Remilk is the first Israeli company in the dairy alternatives sector to obtain FDA approval. The company plans to begin marketing its proteins to the food industry in the coming quarters. However, it still needs to undergo a longer process to receive regulatory marketing approval in Europe and Israel. Remilk has raised over $130 million to date. The approval signifies that Remilks proteins are considered safe for consumption in food and beverages, making them suitable for use in non-animal varieties of popular consumer products. Remilk is working with regulators globally to offer its products in other countries.

growth-positive

Israeli alternative dairy pioneer Remilk is building the world’s largest precision fermentation facility to produce milk proteins without cows. The facility will be located in Kalundborg, Denmark and is part of the Kalundborg Symbiosis project. Remilk uses yeast from the brewing and baking industry to ferment chemically identical milk proteins, allowing manufacturers to create milk, cheese, and yogurt without cholesterol, lactose, hormones, or antibiotics. The company raised $120 million in January 2022.

growth-positive

Remilk, a food startup focused on reimagining the dairy industry, has raised $120 million in Series B funding led by Hanaco Ventures. This funding positions Remilk as a leader in the cultivated dairy category, allowing it to scale production of its animal-free milk proteins. Remilks innovative yeast-based fermentation process produces milk proteins that are indistinguishable from cow milk proteins but are free of lactose, cholesterol, and growth hormones. The process is also environmentally friendly, using significantly less land, water, and emitting fewer greenhouse gases compared to traditional dairy production. The funding will accelerate Remilks manufacturing capabilities and enable commercialization at scale, with products expected in the market later this year.

growth-positive

Israeli animal-free dairy startup Remilk has raised $120 million in a Series B funding round, resulting in a valuation of $325 million, which is ten times its valuation from one year ago. The funding round was led by Hanaco Ventures and included several other investors. Remilk has developed a method of producing animal-free dairy products through microbial fermentation. The companys products are indistinguishable from traditional dairy products and have a smaller environmental footprint. Remilk has already signed deals with numerous dairy manufacturers and expects its product to become commercial in the coming year. The company projects that its sales will reach $600 million by 2026.

growth-positive

Israeli animal-free dairy startup Remilk has raised $11.3 million in a series A funding round. The round was led by fresh.fund and included participation from CPT Capital, OurCrowd, ProVeg, and food manufacturers Hochland, Tnuva, and Tempo, among others. Remilk produces dairy products without the use of animals, using microbial fermentation. The products are said to be indistinguishable from traditional dairy products in terms of flavor, texture, and nutritional value, while being more environmentally friendly.